Controlled Strategies and estimation of trace toxic solvents in pharmaceuticals

Read full text Summarise with VIRAT
Authors: Dharmpal Singh, Prachi Diwakar, Priyanka Mathur
Cited by: 0
References: 8

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Residual solvents in pharmaceuticals refer to volatile organic chemicals that are used during the manufacture of drug substances and finished drug products. Solvents play an essential role in producing active pharmaceutical ingredients (APIs) and drug products, as their proper selection can improve reaction efficiency and influence important properties such as crystal structure, purity, and solubility. Because solvents and their related impurities are integral to the manufacturing process, they may not be fully eliminated during processing and can remain in the final product. As a result, controlling residual solvents is a critical aspect of pharmaceutical development and manufacturing. Tests for residual solvents are generally not specified in individual monographs because the types of solvents used may differ between manufacturers. These solvents can pose risks not only to the environment but also to patient safety if present above acceptable levels. Therefore, acceptable limits for residual solvents are established in the ICH guideline Q3C (R9). This guideline classifies residual solvents into three categories based on their potential risk to human health, taking into account toxicity data and environmental concerns. Class 1 solvents—including benzene (2 ppm), carbon tetrachloride (4 ppm), 1,2-dichloroethane (5 ppm), 1,1-dichloroethane (8 ppm), and 1,1-trichloroethane (1500 ppm)—should be avoided in pharmaceutical manufacturing because they are recognized human carcinogens, highly toxic, and environmentally hazardous, with some also contributing to ozone depletion. Nevertheless, trace amounts of these solvents may still be present as impurities in other commonly used solvents. For example, benzene may be found in ethanol, methanol, acetone, and isopropyl alcohol, while 1,1-dichloroethane and 1,1-trichloroethane may occur in dichloromethane. Therefore, it is essential to carefully monitor and strictly control the levels of these harmful solvents in the solvents used during pharmaceutical manufacturing.

Fields of Study & Subjects

Analytical Methods in Pharmaceuticals Analytical chemistry methods development Chemistry and Chemical Engineering

Publication details

Journal / source
International Journal For Multidisciplinary Research
Volume
8
Issue
2
Publication date
20 March 2026
Language
EN